Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival

Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast... J Cancer Res Clin Oncol (2017) 143:1823–1831 DOI 10.1007/s00432-017-2425-3 ORIGINAL ARTICLE – CLINICAL ONCOLOGY Personalized axillary dissection: the number of excised lymph nodes of nodal‑positive breast cancer patients has no significant impact on relapse‑free and overall survival 1 2 1 1 Florian Ebner · Achim Wöckel · Wolfgang Janni · Rolf Kreienberg · 1 3 Lukas Schwentner · Manfred Wischnewsky Received: 14 March 2017 / Accepted: 13 April 2017 / Published online: 24 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract RFS were intrinsic subtypes (p < 0.001) and tumor size Purpose Sentinel lymph node (SLN) biopsy has replaced (p < 0.001) and for OAS age (p < 0.001) and intrinsic sub- axillary lymph node dissection (ALND) for the staging of types (p < 0.001). There were no significant differences in clinically node-negative breast cancer patients (BCP), dem- RFS and OAS in any subgroup stratified by the number of onstrating equivalent survival to ALND while resulting in excised lymph nodes. Only for T3/T4 tumors, there is a reduced morbidity. ALND has remained the standard of very small significant advantage of ALND for RFS but not care for the majority of BCP with clinical axillary metasta- for OAS. After adjusting http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival

Loading next page...
 
/lp/springer_journal/personalized-axillary-dissection-the-number-of-excised-lymph-nodes-of-STuPqzbzNa
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2425-3
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial